163 related articles for article (PubMed ID: 1770641)
1. [Evaluation of 201Tl SPECT in patients with glioma: a comparative study with histological diagnosis, clinical feature and proliferative activity].
Oriuchi N; Tamura M; Shibazaki T; Inoue T; Watanabe N; Tateno M; Tomiyoshi K; Hirano T; Igarashi H; Endo K
Kaku Igaku; 1991 Nov; 28(11):1263-71. PubMed ID: 1770641
[TBL] [Abstract][Full Text] [Related]
2. Clinical evaluation of thallium-201 SPECT in supratentorial gliomas: relationship to histologic grade, prognosis and proliferative activities.
Oriuchi N; Tamura M; Shibazaki T; Ohye C; Watanabe N; Tateno M; Tomiyoshi K; Hirano T; Inoue T; Endo K
J Nucl Med; 1993 Dec; 34(12):2085-9. PubMed ID: 8254391
[TBL] [Abstract][Full Text] [Related]
3. Semiquantitative analysis using thallium-201 SPECT for differential diagnosis between tumor recurrence and radiation necrosis after gamma knife surgery for malignant brain tumors.
Matsunaga S; Shuto T; Takase H; Ohtake M; Tomura N; Tanaka T; Sonoda M
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):47-52. PubMed ID: 22541963
[TBL] [Abstract][Full Text] [Related]
4. Correlation of histopathological features and proliferative potential of gliomas.
Germano IM; Ito M; Cho KG; Hoshino T; Davis RL; Wilson CB
J Neurosurg; 1989 May; 70(5):701-6. PubMed ID: 2709110
[TBL] [Abstract][Full Text] [Related]
5. Detection of recurrent gliomas with quantitative thallium-201/technetium-99m HMPAO single-photon emission computerized tomography.
Carvalho PA; Schwartz RB; Alexander E; Garada BM; Zimmerman RE; Loeffler JS; Holman BL
J Neurosurg; 1992 Oct; 77(4):565-70. PubMed ID: 1527616
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of malignancy in ring enhancing brain lesions on CT by thallium-201 SPECT.
Källén K; Heiling M; Andersson AM; Brun A; Holtås S; Ryding E; Rosén I
J Neurol Neurosurg Psychiatry; 1997 Nov; 63(5):569-74. PubMed ID: 9408094
[TBL] [Abstract][Full Text] [Related]
7. Thallium-201 single-photon emission computed tomography as an early predictor of outcome in recurrent glioma.
Vos MJ; Hoekstra OS; Barkhof F; Berkhof J; Heimans JJ; van Groeningen CJ; Vandertop WP; Slotman BJ; Postma TJ
J Clin Oncol; 2003 Oct; 21(19):3559-65. PubMed ID: 12913097
[TBL] [Abstract][Full Text] [Related]
8. Correlation of thallium-201 uptake with proliferating cell nuclear antigen in brain tumours.
Gungor F; Bezircioglu H; Guvenç G; Tezcan M; Yildiz A; Uluc E; Isisag A
Nucl Med Commun; 2000 Sep; 21(9):803-10. PubMed ID: 11065152
[TBL] [Abstract][Full Text] [Related]
9. The correlation between 99mTc-MIBI uptake and MIB-1 as a nuclear proliferation marker in glioma--a comparative study with 201Tl.
Nagamachi S; Jinnouchi S; Nabeshima K; Nishii R; Flores L; Kodama T; Kawai K; Tamura S; Yokogami K; Samejima T; Wakisaka S
Neuroradiology; 2001 Dec; 43(12):1023-30. PubMed ID: 11792039
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the extension of cerebral gliomas by scintigraphy.
Weckesser M; Matheja P; Rickert C; Löttgen J; Palkovic S; Riemann B; Paulus W; Wassmann H; Schober O
Strahlenther Onkol; 2000 Apr; 176(4):180-5. PubMed ID: 10812391
[TBL] [Abstract][Full Text] [Related]
11. Independent thallium-201 accumulation and fluorine-18-fluorodeoxyglucose metabolism in glioma.
Oriuchi N; Tomiyoshi K; Inoue T; Ahmad K; Sarwar M; Tokunaga M; Suzuki H; Watanabe N; Hirano T; Horikoshi S; Shibasaki T; Tamura M; Endo K
J Nucl Med; 1996 Mar; 37(3):457-62. PubMed ID: 8772644
[TBL] [Abstract][Full Text] [Related]
12. Variability in the proliferative potential of human gliomas.
Hoshino T; Nagashima T; Cho KG; Davis RL; Donegan J; Slusarz M; Wilson CB
J Neurooncol; 1989 Jul; 7(2):137-43. PubMed ID: 2550593
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of the proliferative potential of intracranial gliomas measured by bromodeoxyuridine labeling.
Hoshino T; Ahn D; Prados MD; Lamborn K; Wilson CB
Int J Cancer; 1993 Feb; 53(4):550-5. PubMed ID: 8382191
[TBL] [Abstract][Full Text] [Related]
14. In situ cell kinetics studies on human neuroectodermal tumors with bromodeoxyuridine labeling.
Hoshino T; Nagashima T; Murovic JA; Wilson CB; Edwards MS; Gutin PH; Davis RL; DeArmond SJ
J Neurosurg; 1986 Mar; 64(3):453-9. PubMed ID: 3950723
[TBL] [Abstract][Full Text] [Related]
15. Clinical evaluation of thallium-201 single photon emission computed tomography in equivocal neuroradiological supratentorial lesions.
Cipri S; Mannino R; Ruggieri R; Gambardella G
J Neurosurg Sci; 2001 Jun; 45(2):75-82. PubMed ID: 11533531
[TBL] [Abstract][Full Text] [Related]
16. Thallium-201 SPECT in prognostic assessment of malignant gliomas treated with postoperative radiotherapy.
Semba T; Sugawara Y; Ochi T; Fujii T; Mochizuki T; Ohnishi T
Ann Nucl Med; 2006 May; 20(4):287-94. PubMed ID: 16856572
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of malignancy and viability of brain tumors by 201Tl SPECT: the correlation between 201Tl SPECT and pathology, clinical progress and the intensity of enhancement on CT images].
Ohnishi H; Koizumi K; Uchiyama G; Yamaguchi M; Okada J; Ogata H; Toyama K; Monzawa S; Oba H; Araki T
Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Dec; 54(14):1388-98. PubMed ID: 7596768
[TBL] [Abstract][Full Text] [Related]
18. [Differential diagnosis between recurrence of gliomas and radiation necrosis by 201TlCl SPECT].
Nakamura O; Kosuda S; Okamoto K; Kaneko M; Nakamura H; Shitara N; Suzuki K
No To Shinkei; 1994 Nov; 46(11):1051-7. PubMed ID: 7873278
[TBL] [Abstract][Full Text] [Related]
19. Final report on the University of California-San Francisco experience with bromodeoxyuridine labeling index as a prognostic factor for the survival of glioma patients.
Lamborn KR; Prados MD; Kaplan SB; Davis RL
Cancer; 1999 Feb; 85(4):925-35. PubMed ID: 10091772
[TBL] [Abstract][Full Text] [Related]
20. Contribution of thallium-201-SPECT to the grading of tumorous alterations of the brain.
Burkard R; Kaiser KP; Wieler H; Klawki P; Linkamp A; Mittelbach L; Göller T
Neurosurg Rev; 1992; 15(4):265-73. PubMed ID: 1480273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
